-
Are you tailoring or losing tolerance?
01 August 2024
ANH Founder, Rob Verkerk PhD, introduces our Tailoring Tolerance Series for August 2024
-
Natural News Roundup (week 06/2022)
10 February 2022
Vitamin C and cancer; Calls for harmonisation of botanicals in EU; When is the menopause, not the menopause?; Chronic disease increases dementia risk; Exercise & type 2 diabetes; Antibiotics increase cancer risk; Junk food marketing
-
From Unreal to Real Food
01 May 2019
Powerful coalition to promote sustainable agriculture, lifestyle and diet kicks off in Somerset, UK
-
Student diet transformation: from junk to health
03 October 2024
Graduate student Molly Bull has been working with ANH as an intern this summer and thinks she’s found a way to transform student diets and eating habits.
News / Food4Health Campaign / Food / Research
-
August Tailoring Tolerance 2024: Chronic stress: the manageable modern-day scourge
08 August 2024
A wander into the world of stress during International Stress Awareness Week
-
Does mould matter?
21 March 2024
We joined Colab Services on 9th March to find out why the answer is a resounding Yes!
-
Want a quick fix for weight loss this January?
12 January 2024
In-house ANH nutrition practitioners, Meleni Aldridge and Melissa Smith, take you on a journey through the options, from gastric bands to semaglutide injections, then showing you why natural approaches targeting metabolic flexibility are best
-
Feature: Is there such a thing as the ‘menopause brain’?
22 February 2024
Read on if you're menopausal and think you're losing your mind. Find out why you’re actually not, why your brain, like the rest of your body, is going through an important transition—and what you can do naturally to get back on track
-
ANH News Beat (week 30/2023)
27 July 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Regulatory limbo: the case of NAC
13 April 2023
The more effective a natural product, the greater the risk if it sits in an uncertain, regulatory ‘no man’s land’